Clinical trial
A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER…
NCT00195754 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00195754 |
|---|---|
| Title | A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488. |
| Official title | The Safety of Divalproex Sodium Extended Release Tablets in Migraine Prophylaxis: An Open-Label Extension Study in Adolescents |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Migraines |
| Intervention type | Drug |
| Interventions | divalproex sodium |
| Enrollment | 114 |
| Start date | Jul 1, 2004 |
| First posted | Sep 20, 2005 |
| Last update posted | Jul 31, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: